Plunkett Research Online: AVEO Pharmaceuticals Inc

AVEO PHARMACEUTICALS INC (AVEO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AVEO Pharmaceuticals, Inc. is a cancer therapeutics company committed to discovering, developing and commercializing targeted cancer therapies. The firm is seeking to develop multiple new drugs that target important mechanisms known, or believed to be involved, in cancer. AVEO’s Human Response Pla.....



AVEO Pharmaceuticals Inc
Ticker: AVEO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 299-5000
Fax:
Address: One Broadway
14th Floor
Cambridge, MA 02142 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs (Pharmaceuticals), Discovery & Manufacturing
ContactsDescription
Michael BaileyCEO/Director/President
Matthew DallasCFO/Chief Accounting Officer
See More
AVEO Pharmaceuticals, Inc. is a cancer therapeutics company committed to discovering, developing and commercializing targeted cancer therapies. The firm is seeking to develop multiple new drugs that target important mechanisms known, or believed to be involved, in cancer. AVEO’s Human Response Pla.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Wilmer Cutler Pickering Hale and Dorr LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Human Response Platform
Tivozanib
Ficlatuzumab
AV-203
AV-380
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: